Inactive Instrument

Highlights ZIVO Bioscience, Inc. Other OTC

Equities

ZIVO

US98978N1019

Highlights

Unlock all the news: Be the first to know and act before the market!

ZIVO Bioscience, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024	14/05	CI
ZIVO Bioscience, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023	16/03	CI
ZIVO Bioscience, Inc. Reports Additional Findings from Positive 42-Day Coccidiosis Challenge Study	08/02	CI
Zivo Bioscience Reports Positive Efficacy Results from 42-Day Validation Study with Non-Antibiotic Immune-Modulating Product for the Prevention and Treatment of Coccidiosis in Broiler Chickens	23/01	CI
ZIVO Bioscience, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	14/11	CI
Reverse Split: 1 of 6	27/23/27	FA
Trial Results Confirm Efficacy of ZIVO Bioscience?s Non-Antibiotic Product Candidate for the Prevention and Treatment of Coccidiosis in Broiler Chickens	20/23/20	CI
ZIVO Bioscience, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023	15/23/15	CI
Zivo Bioscience, Inc. Commences Sales of Its Proprietary Algal Biomass as Human Food	27/23/27	CI
Zivo Bioscience, Inc. Announces its GRAS Designation Reaffirmed for Proprietary Algal Biomass Product as Human Food Ingredient	30/23/30	CI
ZIVO Bioscience, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2023	11/23/11	CI
ZIVO Bioscience, Inc. Reports Earnings Results for the Full Year Ended December 31, 2022	15/23/15	CI
ZIVO Bioscience, Inc. Reports Earnings Results for the Full Year Ended December 31, 2022	15/23/15	CI
North American Morning Briefing : Stock Futures Hold Steady As Inflation Data Looms	13/23/13	DJ
ZIVO Bioscience, Inc. Announces Results of Study with Its Product Candidate for the Prevention and Treatment of Coccidiosis in Broiler Chickens	11/23/11	CI
ZIVO Bioscience, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2022	15/22/15	CI
ZIVO Bioscience, Inc. Announces Plans to Create ZIVOLife LLC	25/22/25	CI
ZIVO Bioscience, Inc. Reports USDA Claims Regulatory Jurisdiction for New Coccidiosis Treatment	11/22/11	CI
ZIVO Bioscience, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2022	05/22/05	CI
ZIVO Bioscience, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2022	14/22/14	CI

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Highlights ZIVO Bioscience, Inc. Other OTC

Equities

ZIVO

US98978N1019

Highlights

Filters